ArticleCureus2022

The Impact of Elexacaftor/Ivacaftor/Tezacaftor on Cystic Fibrosis Patients Who Acquire COVID-19 Infection.

Brittany Miles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.